Registry Stop Signal

allogeneic tumor cell vaccine

allogeneic tumor cell vaccine is flagged as registry stop signal because public records show a registry stop signal. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.

Program overview

Context

Indication: Prostate Cancer

Mechanism: Unknown

Modality: Unknown

Sponsor: Mayo Clinic

Scores

Risk-signal summary

Registry: 5/5

Timeline: 1/5

Recruitment burden: 0/5

Results availability: 0/5

Program risk: 3/5

Evidence

Public links

https://clinicaltrials.gov/study/NCT00814892

Linked trials

Trial-level signal details

TrialStatusTimelineResultsBurden
NCT00814892Registry Stop Signal (TERMINATED)stale_update_signalLow SignalNone